Genesis Molecular AI alternatives and competitors
The closest alternatives to Genesis Molecular AI are Numerion Labs, Iktos, Superluminal Medicines and Aqemia.
Stanford spinout, now trading as Genesis Molecular AI, building GEMS, a small molecule discovery platform its own chemists and its partners' programs run on.
10 alternatives to Genesis Molecular AI
What each product does, with its price as the vendor publishes it.
-
N
Numerion Labs, formerly known as Atomwise, is a San Francisco AI drug discovery company developing small molecules for immune and inflammatory disease, led by chief executive Steve Worland.
Price: No published price
-
I
Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016.
Price: No published price
-
S
Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Price: No published price
-
A
Aqemia designs small molecule drug candidates with Qemi, a platform that joins physics based prediction of how tightly a molecule binds its target with generative AI that proposes new molecules.
Price: No published price
-
T
Terray Therapeutics is a Los Angeles small molecule company whose founding argument is about data rather than models. Its chief executive Jacob Berlin put it plainly at the Series A: even the most powerful artificial intelligence cannot get past insufficient or unclear data.
Price: Not applicable
-
P
PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Where Immunai, Cellarity and Enveda build models of cells, tissue or natural product chemistry to decide what to make, PostEra builds models of how to make it.
Price: No published price
-
C
San Francisco company that licenses foundation models for molecular design to pharmaceutical and life sciences research organizations, rather than using them to build its own pipeline.
Price: No published price
-
V
Variational AI develops Enki, a generative model for designing small molecules against a research team's target product profile.
Price: Custom project pricing
-
X
XtalPi is a drug and materials discovery company founded in Boston in 2015 by three MIT postdoctoral physicists, headquartered in Shenzhen and listed on the Hong Kong Stock Exchange (2228) since 2024.
Price: No published price
-
I
Isomorphic Labs is a London based AI drug design company founded in 2021 by Sir Demis Hassabis, who leads it as chief executive.
Price: Not applicable
Genesis Molecular AI alternatives, answered
What are the best alternatives to Genesis Molecular AI?
The closest alternatives to Genesis Molecular AI are Numerion Labs, Iktos, Superluminal Medicines, Aqemia and Terray Therapeutics. Numerion Labs, formerly known as Atomwise, is a San Francisco AI drug discovery company developing small molecules for immune and inflammatory disease, led by chief executive Steve Worland. Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016. Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Who are Genesis Molecular AI's competitors?
Genesis Molecular AI's competitors in the Drug Discovery AI category include Numerion Labs, Iktos, Superluminal Medicines, Aqemia, Terray Therapeutics and PostEra.